Welcome and Introduction

Transcript/slides only version.

Interferon alfa-2b/Ribavirin Combination Therapy in Treatment-Naive Patients

Transcript/slides only version.

Interferon alfa-2b/Ribavirin Combination Therapy in Other Patient Populations (Relapsers, Nonresponders, and Liver Transplant Recipients)

Transcript/slides only version.

Robert G. Gish, MD

Emerging Therapies for Chronic Hepatitis C

Transcript/slides only version.

Adrian M.
Di Bisceglie, MD

Panel Discussion

Transcript/slides only version.

Summary/Concluding Remarks

Transcript/slides only version.

Notice

Some of the cutting-edge data presented at this symposium are from recently completed, unpublished studies. For this reason, the online presentation does not contain the complete set of slides presented during the live meeting.

Disclaimer

This CME activity is planned and produced in accordance with the ACCME Essentials and Standards for Commercial Support. The editorial content of this Web site expresses the views of the individual contributors and does not necessarily reflect the views or recommendations of the AASLD, AGA, ASGE, SSAT, Projects In Knowledge, or Slack Incorporated. This activity may include a discussion of therapies that are unapproved for use or investigational, ongoing research, or preliminary data.